Whole-genome methylation analysis provides a comprehensive, single-base-resolution map of DNA methylation across the entire genome, revealing how epigenetic modifications regulate gene expression in development, disease, and environmental responses. This technical guide explains the core principles of whole-genome methylation profiling, mainstream detection methods such as WGBS and enzymatic methyl-seq, sample requirements, testing items, and typical applications in life science research and clinical studies.
Technical Overview
DNA methylation is one of the most extensively studied epigenetic modifications, involving the covalent addition of a methyl group to the carbon-5 position of cytosine to form 5-methylcytosine (5mC). In mammals, methylation occurs predominantly at CpG dinucleotides, while in plants it is also found in CHG and CHH sequence contexts. Methylation plays a central role in transcriptional regulation, genomic imprinting, X-chromosome inactivation, silencing of transposable elements, and maintenance of chromatin structure.
Whole-genome methylation analysis refers to the unbiased, comprehensive profiling of DNA methylation status across the entire genome, most commonly achieved through whole-genome bisulfite sequencing (WGBS). The fundamental principle relies on chemical or enzymatic conversion: unmethylated cytosines are converted to uracil (and subsequently read as thymine after PCR amplification), while methylated cytosines remain unconverted. By aligning the converted sequencing reads against a reference genome, the methylation state of virtually every cytosine in the genome can be determined at single-base resolution.
Compared with targeted or reduced-representation approaches, whole-genome methylation analysis delivers complete coverage of promoters, gene bodies, intergenic regions, enhancers, repeat elements, and low-CpG-density regions, making it the gold-standard method for discovering novel methylation biomarkers and building comprehensive epigenomic maps. Studies performed in accredited third-party laboratories or core sequencing facilities typically follow ISO/IEC 17025-aligned quality management practices to ensure data reliability and reproducibility.
Testing Samples
Animal Tissues and Blood Samples
Fresh or flash-frozen animal tissues and whole blood are the most common sample types for whole-genome methylation analysis. Recommended inputs are typically 500 ng to 1 µg of high-quality genomic DNA with an OD260/280 ratio of 1.8–2.0 and minimal degradation. Blood samples should be collected in EDTA tubes, and tissues should be snap-frozen in liquid nitrogen and stored at −80 °C to prevent endonuclease-mediated DNA degradation.
Plant Tissue Samples
Plant genomes contain substantial methylation in the CHG and CHH contexts, and whole-genome profiling is particularly valuable for studying hybrid vigor, stress responses, and transposon silencing. Young leaves are the preferred tissue because of their low polysaccharide and polyphenol content. Chloroplast DNA methylation rates are also often evaluated as an internal control of conversion efficiency in plant experiments.
FFPE and Archived Specimens
Formalin-fixed paraffin-embedded (FFPE) tissues can be analyzed using specialized low-input and DNA-repair-compatible library preparation protocols. Because formalin fixation causes fragmentation and cross-linking, DNA extraction methods optimized for archived specimens are recommended, and the minimum fragment size should generally exceed 200 bp for reliable library construction.
Cell-Free DNA and Liquid Biopsy Samples
Plasma-derived circulating cell-free DNA (cfDNA) supports non-invasive methylation profiling for early cancer detection and disease monitoring. Typically, 10–20 mL of peripheral blood is collected in specialized tubes, plasma is separated by centrifugation, and cfDNA is extracted yielding 5–50 ng of DNA. Ultra-low-input library preparation protocols are applied to accommodate limited material.
Single-Cell and Ultra-Low-Input Samples
Embryos, rare cell populations, and circulating tumor cells can be profiled using single-cell bisulfite sequencing workflows. These methods require optimized amplification strategies to mitigate coverage bias, and results should be interpreted with awareness of amplification-related allelic dropout.
Testing Items
Standard deliverables of a whole-genome methylation analysis project include:
- Genome-wide 5mC profiling at single-cytosine resolution, reported as methylation levels (percentage of methylated reads at each cytosine)
- Global methylation level calculation (total methylated cytosines / total cytosines sequenced)
- Methylation distribution across functional genomic regions, including promoters, CpG islands, gene bodies, enhancers, and repeat elements
- Identification of differentially methylated regions (DMRs) and differentially methylated positions (DMPs) between comparative groups
- Sequence context analysis of methylation patterns (CpG, CHG, and CHH) for plant and other non-mammalian genomes
- Chromosome-level methylation landscape visualization and Circos plot reporting
- Methylation haplotype block analysis and, optionally, epigenetic age estimation
- Integration of methylation data with transcriptomic data for joint epigenetic regulation analysis
Testing Methods
Whole-Genome Bisulfite Sequencing (WGBS)
WGBS is the benchmark method for whole-genome methylation analysis. Genomic DNA is fragmented, ligated with methylated adapters to preserve original methylation information, treated with sodium bisulfite to convert unmethylated cytosines to uracil, amplified by PCR, and sequenced to a typical depth of 30× per sample. Bisulfite conversion efficiency should exceed 99%, verified using unmethylated spike-in controls such as lambda DNA. Key quality metrics include mapping rate, duplication rate, sequencing depth, and bisulfite conversion rate.
Enzymatic Methyl Sequencing (EM-Seq)
EM-Seq replaces harsh chemical bisulfite treatment with an enzymatic conversion cascade that deaminates unmethylated cytosines. This approach substantially reduces DNA degradation and strand loss, improves mapping rates and coverage uniformity, and enables high-quality libraries from as little as 10 ng of input DNA, making it well suited for cfDNA and FFPE-derived samples.
Third-Generation Direct Methylation Detection
Single-molecule real-time sequencing and nanopore-based platforms can detect methylated bases directly from native DNA without amplification or chemical conversion. These technologies preserve long-range haplotype information, enable methylation phasing across chromosomal regions, and can distinguish certain modification types, though analytical pipelines require platform-specific statistical models.
Complementary Hybrid Capture and Array Approaches
For large-cohort studies or predefined regions of interest, high-density methylation arrays covering known CpG sites and hybrid-capture targeted methylation panels offer cost-effective alternatives, accepting trade-offs in discovery scope relative to unbiased whole-genome profiling.
Bioinformatics Analysis Pipeline
Data analysis follows a structured workflow: raw read quality assessment, adapter and low-quality trimming, alignment using bisulfite-aware aligners, methylation calling at each cytosine, filtering of low-confidence sites, DMR and DMP detection using statistical models, functional annotation against genomic features, enrichment analysis of affected biological pathways, and generation of genome-wide visualization plots. All raw data (FASTQ), alignment files, methylation call files, and analysis reports are provided as standard deliverables.
Applications
Whole-genome methylation analysis supports a wide range of research and translational applications:
- Oncology and cancer biomarker discovery: detection of global hypomethylation, promoter CpG island hypermethylation of tumor suppressor genes, and tumor-specific methylation signatures for early diagnosis, prognosis, and classification.
- Liquid biopsy and non-invasive diagnostics: cfDNA methylation markers for early cancer screening, minimal residual disease monitoring, and treatment response evaluation.
- Developmental and stem cell biology: characterization of methylation reprogramming during embryogenesis, genomic imprinting, and pluripotency maintenance.
- Aging research: construction and application of epigenetic clocks based on CpG methylation patterns to estimate biological age.
- Plant genetics and breeding: analysis of methylation variation associated with hybrid vigor, stress tolerance, and epigenetic inheritance in crops.
- Environmental epigenetics and toxicology: assessment of methylation changes induced by pollutants, nutrition, and other environmental exposures.
- Neuroscience and immunology: investigation of epigenetic mechanisms underlying neurodegenerative diseases, psychiatric disorders, and immune cell differentiation.
- Reproductive medicine: evaluation of imprinting disorders, embryo quality assessment, and placental epigenetic studies.
FAQ
How much DNA is required for whole-genome methylation analysis?
Standard WGBS workflows typically require 500 ng to 1 µg of high-quality genomic DNA. Enzymatic conversion-based protocols can generate high-quality libraries from 10–100 ng, and optimized low-input or single-cell workflows can work with even less material. DNA integrity should be verified by agarose gel electrophoresis or fragment analysis before library preparation.
What sequencing depth is recommended?
A depth of approximately 30× per sample is recommended for comprehensive, publication-quality whole-genome methylation maps. Lower depths of 5–10× may be acceptable for preliminary surveys or large-cohort comparative studies with appropriate statistical correction.
How does WGBS differ from RRBS and methylation arrays?
WGBS covers virtually all cytosines genome-wide, offering the highest discovery power. Reduced-representation bisulfite sequencing (RRBS) enriches CpG-dense regions near promoters, covering a limited fraction of the genome at reduced cost. Methylation arrays interrogate hundreds of thousands of predefined CpG sites, providing a cost-efficient solution for large cohorts but no opportunity for novel site discovery.
Can bisulfite sequencing distinguish 5mC from 5hmC?
No. Standard bisulfite conversion cannot differentiate 5-methylcytosine from 5-hydroxymethylcytosine, as both remain unconverted. When 5hmC discrimination is required, oxidative bisulfite sequencing (oxBS-seq), TET-assisted bisulfite sequencing (TAB-seq), or direct third-generation detection methods should be used in combination.
Can FFPE samples and plant samples be analyzed?
Yes. FFPE specimens can be processed using repair-enhanced, low-input protocols when DNA fragments exceed approximately 200 bp. Plant samples are fully supported, with analysis extended to CHG and CHH methylation contexts, and chloroplast methylation can serve as an internal indicator of conversion efficiency.
What is the typical project timeline and final deliverable?
A complete project, from sample QC through library preparation, sequencing, and full bioinformatics analysis, typically requires 4–8 weeks depending on sample type, sequencing depth, and analysis complexity. Final deliverables include raw sequencing data, quality control reports, alignment files, base-resolution methylation call data, DMR and DMP analysis results, annotation tables, and genome-wide visualization figures.